Cover Image

Neoadjuvant therapy for left-sided resectable pancreatic ductal adenocarcinoma: evidence-based shift or premature extrapolation?

Neoadjuvant therapy for left-sided resectable pancreatic ductal adenocarcinoma: evidence-based shift or premature extrapolation?

Saved in:
Bibliographic Details
Main Authors: Uzunoğlu, Faik Güntaç (Author) , Springfeld, Christoph (Author) , Peccerella, Teresa (Author) , Hank, Thomas (Author) , Loos, Martin (Author) , Michalski, Christoph (Author) , Hackert, Thilo (Author) , Neoptolemos, John P. (Author)
Format: Article (Journal) Editorial
Language:English
Published: February 01, 2026
In: Hepatobiliary surgery and nutrition
Year: 2026, Volume: 15, Issue: 1, Pages: 1-4
ISSN:2304-389X
DOI:10.21037/hbsn-2025-587
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.21037/hbsn-2025-587
Verlag, lizenzpflichtig, Volltext: https://hbsn.amegroups.org/article/view/148280
Get full text
Author Notes:Faik G. Uzunoglu, Christoph Springfeld, Teresa Peccerella, Thomas Hank, Martin Loos, Christoph W. Michalski, Thilo Hackert, John P. Neoptolemos
Description
Summary:Neoadjuvant therapy for left-sided resectable pancreatic ductal adenocarcinoma: evidence-based shift or premature extrapolation?
Item Description:Gesehen am 23.03.2026
Online veröffentlicht: Jan 19, 2026
Physical Description:Online Resource
ISSN:2304-389X
DOI:10.21037/hbsn-2025-587

Similar Items